These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12953139)

  • 1. A comparison of antidepressant trials using active and inert placebos.
    Moncrieff J
    Int J Methods Psychiatr Res; 2003; 12(3):117-27. PubMed ID: 12953139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of trials comparing antidepressants with active placebos.
    Moncrieff J; Wessely S; Hardy R
    Br J Psychiatry; 1998 Mar; 172():227-31; discussion 232-4. PubMed ID: 9614471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants using active placebos.
    Moncrieff J; Wessely S; Hardy R
    Cochrane Database Syst Rev; 2001; (2):CD003012. PubMed ID: 11406060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active placebos versus antidepressants for depression.
    Moncrieff J; Wessely S; Hardy R
    Cochrane Database Syst Rev; 2004; 2004(1):CD003012. PubMed ID: 14974002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials.
    Holper L; Hengartner MP
    BMC Psychiatry; 2020 Sep; 20(1):437. PubMed ID: 32894088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are antidepressants overrated? A review of methodological problems in antidepressant trials.
    Moncrieff J
    J Nerv Ment Dis; 2001 May; 189(5):288-95. PubMed ID: 11379971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression.
    Sneed JR; Rutherford BR; Rindskopf D; Lane DT; Sackeim HA; Roose SP
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):65-73. PubMed ID: 17998306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a delay in the antidepressant effect? A meta-analysis.
    Posternak MA; Zimmerman M
    J Clin Psychiatry; 2005 Feb; 66(2):148-58. PubMed ID: 15704999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M; Levitt AJ; Cheung AH; Schaffer A; Kiss A; Dowlati Y; Lanctôt KL
    J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does differential drop-out explain the influence of study design on antidepressant response? A meta-analysis.
    Rutherford BR; Sneed JR; Roose SP
    J Affect Disord; 2012 Sep; 140(1):57-65. PubMed ID: 22387053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side effects and the "blindability" of clinical drug trials.
    White K; Kando J; Park T; Waternaux C; Brown WA
    Am J Psychiatry; 1992 Dec; 149(12):1730-1. PubMed ID: 1443253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical approach to antidepressant trials. Blindness protection is necessary, feasible and measurable.
    Even C; Siobud-Dorocant E; Dardennes RM
    Br J Psychiatry; 2000 Jul; 177():47-51. PubMed ID: 10945088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?
    Trivedi MH; Rush H
    Neuropsychopharmacology; 1994 Aug; 11(1):33-43. PubMed ID: 7945742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.
    Taylor WD; Doraiswamy PM
    Neuropsychopharmacology; 2004 Dec; 29(12):2285-99. PubMed ID: 15340391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA; Reimitz PE; Sennef C
    Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.